Guest post: With cancer on the rise, it’s Iowans’ health vs. chemical companies
We’re in for a big fight next year that will pit multinational chemical companies and their billion-dollar profits against the health and well-being of everyday Iowans.
We’re in for a big fight next year that will pit multinational chemical companies and their billion-dollar profits against the health and well-being of everyday Iowans.
In most states, the ACA's annual open enrollment season for health plans begins Nov. 1 and lasts through Jan. 15. Here's what you need to know.
Eight years after Medicaid privatization, Iowans with disabilities face 7-year waitlists, ‘forced poverty,’ and more. There are 402,615 Iowans who report having a disability, making up nearly 13% of the population. These Iowans face significant challenges in...
Under Harris’ plan, Medicare would cover the cost of in-home health care for seniors enrolled in the program, after a medical provider has determined that they are in need of help performing daily tasks. Harris’ proposal would also provide coverage for vision and hearing benefits under Medicare.
Harris wants to expand the $35 monthly cap on insulin costs and a $2,000 annual cap on out-of-pocket drug costs so that they apply to all Americans, not just seniors on Medicare.
When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what you need to know.
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
For years, Miller-Meeks took thousands from pharmaceutical companies, and she received $1,000 from an insulin manufacturer on the day she voted against a bill to cap insulin prices. Before voting against a bill that would cap insulin costs and allow the government...
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
As summer reaches its peak in Iowa, two new tools designed to assist in heat risk monitoring have become available to the public.